Detalhe da pesquisa
1.
Central nervous system effects of the histamine-3 receptor antagonist CEP-26401, in comparison with modafinil and donepezil, after a single dose in a cross-over study in healthy volunteers.
Br J Clin Pharmacol
; 85(5): 970-985, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30710391
2.
Sub-analysis of geographical variations in the 2-year observational COPTIMIZE trial of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate.
BMC Neurol
; 15: 189, 2015 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26450155
3.
MPOWERED Trial Open-Label Extension: Long-term Efficacy and Safety Data for Oral Octreotide Capsules in Acromegaly.
J Clin Endocrinol Metab
; 108(12): 3214-3222, 2023 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37319438
4.
Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial.
Lancet Diabetes Endocrinol
; 10(2): 102-111, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34953531
5.
Disease and Treatment-Related Burden in Patients With Acromegaly Who Are Biochemically Controlled on Injectable Somatostatin Receptor Ligands.
Front Endocrinol (Lausanne)
; 12: 627711, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33790860
6.
Pathological and clinical aspects of alpha/beta synuclein in Parkinson's disease and related disorders.
Expert Rev Neurother
; 16(5): 505-13, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26959397
7.
Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependence.
Drug Alcohol Depend
; 166: 13-20, 2016 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27394932
8.
Analysis of gene expression in MOG-induced experimental autoimmune encephalomyelitis after treatment with a novel brain-penetrating antioxidant.
J Mol Neurosci
; 27(1): 125-35, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16055951
9.
Therapeutic potential of neurotrophic factors in neurodegenerative diseases.
BioDrugs
; 19(2): 97-127, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15807629
10.
A novel brain-targeted antioxidant (AD4) attenuates haloperidol-induced abnormal movement in rats: implications for tardive dyskinesia.
Clin Neuropharmacol
; 28(6): 285-8, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-16340385
11.
Glatiramer acetate: long-term safety and efficacy in relapsing-remitting multiple sclerosis.
Expert Rev Neurother
; 15(6): 575-86, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25924547
12.
Safety, pharmacokinetics, and pharmacodynamics of TV-1380, a novel mutated butyrylcholinesterase treatment for cocaine addiction, after single and multiple intramuscular injections in healthy subjects.
J Clin Pharmacol
; 55(5): 573-83, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25524052
13.
Antioxidant treatment in Alzheimer's disease: current state.
J Mol Neurosci
; 21(1): 1-11, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-14500988
14.
Axonal damage is reduced following glatiramer acetate treatment in C57/bl mice with chronic-induced experimental autoimmune encephalomyelitis.
Neurosci Res
; 47(2): 201-7, 2003 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-14512144
15.
Riluzole suppresses experimental autoimmune encephalomyelitis: implications for the treatment of multiple sclerosis.
Brain Res
; 989(2): 196-204, 2003 Nov 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-14556941
16.
The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy.
J Neurol
; 251(3): 261-8, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15015004
17.
A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.
J Neurol
; 261(11): 2101-11, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25119836
18.
Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.
J Neurol
; 262(1): 248, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25417969
19.
Anti-inflammatory drugs in the treatment of neurodegenerative diseases: current state.
Curr Pharm Des
; 12(27): 3509-19, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-17017944
20.
A novel thiol antioxidant that crosses the blood brain barrier protects dopaminergic neurons in experimental models of Parkinson's disease.
Eur J Neurosci
; 21(3): 637-46, 2005 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15733082